Segment Reporting and Foreign Operations - Operating Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Net sales	$ 1,356,514	$ 1,257,366	$ 1,150,981
Selling, general and administrative expenses	399,731	373,676	342,525
Income from operations	155,693	123,944	87,563
Total other expense - net	(5,700)	(11,855)	(4,934)
Income before income taxes	149,993	112,089	82,629
Cardiovascular
Segment Reporting Information [Line Items]
Net sales	1,301,744	1,220,560	1,118,224
Cost of sales standard	549,657	534,826	496,678
Cost of sales other	140,948	125,388	121,045
Selling, general and administrative expenses	376,734	362,082	332,012
Research and development expenses	83,812	80,300	74,042
Other operating expenses	443	3,524	13,501
Income from operations	150,150	114,440	80,946
Endoscopy
Segment Reporting Information [Line Items]
Net sales	54,770	36,806	32,757
Cost of sales standard	15,746	12,987	12,739
Cost of sales other	6,830	293	1,420
Selling, general and administrative expenses	22,997	11,594	10,513
Research and development expenses	3,654	2,428	1,468
Income from operations	$ 5,543	$ 9,504	$ 6,617